214 related articles for article (PubMed ID: 2149959)
1. Trisomy 21 in neoplastic cells.
Mitelman F; Heim S; Mandahl N
Am J Med Genet Suppl; 1990; 7():262-6. PubMed ID: 2149959
[TBL] [Abstract][Full Text] [Related]
2. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome.
Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R
Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
[TBL] [Abstract][Full Text] [Related]
4. [Association of congenital chromosome abnormalities and malignant diseases].
Erzsébet B; Andrea N; Róbert S; Eva O
Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomalies.
Alimena G; Billström R; Casalone R; Gallo E; Mitelman F; Pasquali F
Cancer Genet Cytogenet; 1985 Apr; 16(3):207-18. PubMed ID: 3156666
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic biclonality in malignant hematologic disorders.
Furuya T; Morgan R; Sandberg AA
Cancer Genet Cytogenet; 1992 Aug; 62(1):25-8. PubMed ID: 1521230
[TBL] [Abstract][Full Text] [Related]
7. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
Dewald GW; Diez-Martin JL; Steffen SL; Jenkins RB; Stupca PJ; Burgert EO
Am J Med Genet Suppl; 1990; 7():247-50. PubMed ID: 2149957
[TBL] [Abstract][Full Text] [Related]
8. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 13 as a primary chromosome aberration in acute leukemia.
Mertens F; Sallerfors B; Heim S; Johansson B; Kristoffersson U; Malm C; Mitelman F
Cancer Genet Cytogenet; 1991 Oct; 56(1):39-44. PubMed ID: 1747868
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosome abnormalities. A cooperative study. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1988 Oct; 35(2):243-52. PubMed ID: 2972356
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetically unrelated clones in hematological neoplasms.
Heim S; Mitelman F
Leukemia; 1989 Jan; 3(1):6-8. PubMed ID: 2909809
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosome arm 3p in hematologic malignancies.
Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
[TBL] [Abstract][Full Text] [Related]
13. Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders.
Garcia-Isidoro M; Tabernero MD; Najera ML; Lopez-Berges MC; Martinez A; Durán A; Garcia JL; Hernandez JM; Garcia Marcos MA; San Miguel JF; Orfao A
Ann Hematol; 1997 May; 74(5):209-14. PubMed ID: 9200992
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.
Cortes JE; Kantarjian H; O'Brien S; Keating M; Pierce S; Freireich EJ; Estey E
Leukemia; 1995 Jan; 9(1):115-7. PubMed ID: 7845005
[TBL] [Abstract][Full Text] [Related]
15. Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms.
Knuutila S; Teerenhovi L; Larramendy ML; Elonen E; Franssila KO; Nylund SJ; Timonen T; Heinonen K; Mahlamäki E; Winqvist R
Genes Chromosomes Cancer; 1994 Jun; 10(2):95-102. PubMed ID: 7520272
[TBL] [Abstract][Full Text] [Related]
16. Loss of the extra chromosome 21 in a patient with Down syndrome and myelodysplasia.
Tan D; Lau LC; Teng LM; Sane S; Lim TH; Tien SL
Cancer Genet Cytogenet; 2008 Jan; 180(1):79-82. PubMed ID: 18068540
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
18. dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes.
Alfaro R; Pérez-Granero A; Durán MA; Besalduch J; Rosell J; Bernués M
Leuk Res; 2008 Jan; 32(1):159-61. PubMed ID: 17509681
[TBL] [Abstract][Full Text] [Related]
19. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
20. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
